Published in
Elsevier, EClinicalMedicine, (66), p. 102303, 2023
DOI: 10.1016/j.eclinm.2023.102303
Links
Tools
Efficacy and safety of second-line therapy of docetaxel plus ramucirumab after first-line platinum-based chemotherapy plus immune checkpoint inhibitors in non-small cell lung cancer (SCORPION): a multicenter, open-label, single-arm, phase 2 trial
Journal article published in 2023 by
Reiko Matsuzawa,
Masahiro Morise 
,
Kentaro Ito ,
Osamu Hataji,
Kosuke Takahashi,
Junji Koyama,
Yachiyo Kuwatsuka,
Yasuhiro Goto ,
Kazuyoshi Imaizumi,
Hidetoshi Itani,
Teppei Yamaguchi,
Yoshitaka Zenke,
Masahide Oki ,
Makoto Ishii
,
Kentaro Ito ,
Osamu Hataji,
Kosuke Takahashi,
Junji Koyama,
Yachiyo Kuwatsuka,
Yasuhiro Goto ,
Kazuyoshi Imaizumi,
Hidetoshi Itani,
Teppei Yamaguchi,
Yoshitaka Zenke,
Masahide Oki ,
Makoto Ishii
This paper is made freely available by the publisher.
Full text: Download
Data provided by 